Table 1.
Correlation between SNHG16 expression and HCC clinicopathologic features.
| Characteristic | SNHG16 expression level | P-value | |
|---|---|---|---|
| Low N=26 (42.6%) | High N=35 (57.4%) | ||
| Age | 0.149 | ||
| ≤55 | 16 (61.5%) | 15 (42.9%) | |
| >55 | 10 (38.5%) | 20 (57.1%) | |
| Sex | 0.186 | ||
| Male | 16 (61.5%) | 27 (77.1%) | |
| Female | 10 (38.5%) | 8 (22.9) | |
| Tumor size (cm) | 0.031 | ||
| ≤5 | 21 (80.8%) | 19 (54.3%) | |
| >5 | 5 (19.2%) | 16 (45.7%) | |
| Pathologic grade | 0.096 | ||
| I–II | 16 (61.5%) | 14 (40.0%) | |
| III–IV | 10 (38.5%) | 21 (60.0%) | |
| AFP level (ng/ml) | <0.001 | ||
| ≤500 | 23 (88.5%) | 15 (42.9%) | |
| >500 | 3 (11.5%) | 20 (57.1%) | |
| Liver cirrhosis | 0.856 | ||
| With | 15 (57.7%) | 21 (60.0%) | |
| Without | 11 (42.3%) | 14 (40.0%) | |
| PVTT | 0.007 | ||
| No | 25 (96.2%) | 24 (68.6%) | |
| Yes | 1 (3.8%) | 11 (31.4%) | |
| Metastasis | 0.007 | ||
| No | 25 (96.2%) | 24 (68.6%) | |
| Yes | 1 (3.8%) | 11 (31.4%) | |
PTVV – portal vein tumor thrombus.